FYI..........the biological guy at 31 minutes in backs away from testing on the body parts.
So in fact......the bio GUY stepped away from it......................
So Trump did a screw up there..........oh well...........got me looking into it........and found they are actually trying it.........LOL
UV light has been used as a blood treatment for lung cancer patients.
Ultraviolet blood irradiation (UBI) was extensively used in the 1940s and 1950s to treat many diseases including septicemia, pneumonia, tuberculosis, arthritis, asthma and even poliomyelitis. The early studies were carried out by several physicians ...
www.ncbi.nlm.nih.gov
25.5. Modern Devices to Carry Out UBI
Although it is often said that UBI is “the cure that time forgot” [
90,
91], it has not actually been completely forgotten. There are several companies, organizations and devices existing at the present time, which are being used or proposed (on a rather small scale) to carry out UBI, or as it often called “Photoluminescence Therapy (PT)”. Several websites provide information on UBI and PT. Perhaps one of the most comprehensive is (
Photoluminescence Therapy) that provides a listing of practitioners located in USA that offer UBI to patients. UBI medical (
UBI MEDICAL | About Us) also has a lot of information available. The web-site entitled “Infections cured” (
http://infectionscured.com) is also worth checking out. Physicians UBI Awareness Center (
http://drsubi.com) even has a video posted online comparing different kinds of UBI machines.
Go to:
25.6. Conclusion
UV irradiation of blood was hailed as a miracle therapy for treating serious infections in the 1940s and 1950s. In an ironic quirk of fate, this historical time period coincided with the widespread introduction of penicillin antibiotics, which were rapidly found to be an even bigger medical miracle therapy. Moreover another major success of UBI, which was becoming increasingly used to treat polio, was also eclipsed by the introduction of the Salk polio vaccine in 1955 [
91]. UBI had originally been an American discovery, but then was transitioned to being more studied in Russia and other eastern countries, which had long concentrated on physical therapies for many diseases, which were more usually treated with drugs in the West.
However in the last decade the problem of multi-antibiotic resistant bacteria has grown relentlessly. Multidrug-resistant (MDR) and pandrug resistant (PDR) bacterial strains and their related infections are emerging threats to public health throughout the world [
92]. These are associated with approximately two-fold higher mortality rates and considerably prolonged hospital admissions [
93]. The infections caused by antibiotic resistant strains are often exceptionally hard to treat due to the limited range of therapeutic options [
94]. Recently in Feb 2015, the Review on Antimicrobial Resistance stated “Drug- resistant infections could kill an extra 10 million people across the world every year by 2050 if they are not tackled. By this date they could also cost the world around $100 trillion in lost output: more than the size of the current world economy, and roughly equivalent to the world losing the output of the UK economy every year, for 35 years” [
95].
Sepsis is an uncontrolled response to infection involving massive cytokine release, widespread inflammation, which leads to blood clots and leaky vessels. Multi-organ failure can follow. Every year, severe sepsis strikes more than a million Americans. It is estimated that between 28–50% percent of these people die. Patients with sepsis are usually treated in hospital intensive care units with broad-spectrum antibiotics, oxygen and intravenous fluids to maintain normal blood oxygen levels and blood pressure. Despite decades of research, no drugs that specifically target the aggressive immune response that characterizes sepsis have been developed.
We would like to propose that UBI be reconsidered and re-investigated as a treatment for systemic infections caused by multi-drug resistant Gram-positive and Gram-negative bacteria in patients who are running out of (or who have already run out) of options. Patients at risk of death from sepsis could also be considered as candidates for UBI. Further research is required into the mechanisms of action of UBI. The present confusion about exactly what is happening during and after the treatment is playing a large role in the controversy about whether UBI could ever be a mainstream medical therapy, or must remain side-lined in the “alternative and complementary” category where it has been allowed to be forgotten for the last 50 years.
riordanclinic.org
making a fool of himself in his own "best" words.
